B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure

American Heart Journal

Volumn 149, Issue 2, 2005, Pages 363-369

  O'Neill, J O ^a   Bott Silverman, C E ^a   McRae III, A T ^a   Troughton, R W ^a   Ng, K ^a   Starling, R C ^a   Young, J B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; INOTROPIC AGENT; MILRINONE; NITRATE; NITROPRUSSIDE SODIUM; VASODILATOR AGENT;

ACCURACY; ADULT; AGED; ARTERY CATHETER; ARTERY CATHETERIZATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PULMONARY ARTERY OCCLUSION; RETROSPECTIVE STUDY; UNITED STATES; VALVULAR HEART DISEASE;

EID: 14844333579     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.05.051     Document Type: Article

References (21)

1. E.M. Gilbert Cost-effectiveness of β-blocker treatment in heart failure Rev. Cardiovasc. Med. 3 Suppl. 3 2002 S42 S47
2. M.R. Shah, V. Hasselblad, and S.S. Stinnett Hemodynamic profiles of advanced heart failure: association with clinical characteristics and long-term outcomes J. Card Fail 7 2001 105 113
3. M.R. Shah, C.M. O'Connor, and G. Sopko Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness (ESCAPE): design and rationale Am. Heart J. 141 2001 528 535
4. M.R. Burger, and A.J. Burger BNP in decompensated heart failure: diagnostic, prognostic and therapeutic potential Curr. Opin. Investig. Drugs 2 2001 929 935
5. M.R. Cowie, and G.F. Mendez BNP and congestive heart failure Prog. Cardiovasc. Dis. 44 2002 293 321
6. A. Harrison, L.K. Morrison, and P. Krishnaswamy B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea Ann. Emerg. Med. 39 2002 131 138
7. W.Ft. Peacock The B-type natriuretic peptide assay: a rapid test for heart failure Cleve. Clin. J. Med. 69 2002 243 251
8. M. Hulsmann, R. Berger, and B. Sturm Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota living with heart failure questionnaire in an outpatient cohort with congestive heart failure Eur. Heart J. 23 2002 886 891
9. R. Berger, M. Huelsman, and K. Strecker B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 105 2002 2392 2397
10. K. Maeda, T. Tsutamoto, and A. Wada High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure J. Am. Coll. Cardiol. 36 2000 1587 1593
11. R.W. Troughton, C.M. Frampton, and T.G. Yandle Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet. 355 2000 1126 1130
12. R. Kazanegra, V. Cheng, and A. Garcia A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study J. Card. Fail 7 2001 21 29
13. W. Johnson, T. Omland, and C. Hall Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure J. Am. Coll. Cardiol. 39 2002 1623 1629
14. A.E. Steimle, L.W. Stevenson, and C. Chelimsky-Fallick Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure Circulation 96 1997 1165 1172
15. R.M. Mills, and J.B. Young Heart failure therapy: not as complicated as it looks Clin. Cardiol. 22 1999 333
16. L.W. Stevenson, B.M. Massie, and G.S. Francis Optimizing therapy for complex or refractory heart failure: a management algorithm Am. Heart J. 135 6 Pt 2 Su 1998 S293 S309
17. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N. Engl. J. Med. 347 2002 161 167
18. A.M. Richards, J.G. Lainchbury, and M.G. Nicholls BNP in hormone-guided treatment of heart failure Trends Endocrinol. Metab. 13 2002 151 155
19. V. Cheng, R. Kazanagra, and A. Garcia A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study J. Am. Coll. Cardiol. 37 2001 386 391
20. G.C. Fonarow, L.W. Stevenson, and J.A. Walden Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure J. Am. Coll. Cardiol. 30 1997 725 732
21. T.J. Wang, M.G. Larson, and D. Levy Heritability and genetic linkage of plasma natriuretic peptide levels Circulation 108 2003 13 16